Birmingham, West Midlands -- (SBWIRE) -- 12/17/2013 -- Value Penny Stocks issues special report on Real Goods Solar, Inc. (NASDAQ:RSOL), PDL BioPharma Inc. (NASDAQ:PDLI), Galena Biopharma Inc (NASDAQ:GALE), MannKind Corporation (NASDAQ:MNKD).
Real Goods Solar, Inc. (NASDAQ:RSOL) closed at the price of $2.17 after opening at $2.24. The stock traded during its last trading session with the total volume of 3,646,153 shares, as compared to its average volume of 2.64 million shares. Real Goods Solar, Inc. operates as a residential and commercial solar energy engineering, procurement, and construction company in the United States. It provides commercial and residential solar energy solutions.
Should RSOL a Buy or Sell Now? Find Out Here
PDL BioPharma Inc. (NASDAQ:PDLI) traded with volume of 3,635,773 shares in the last session, as compared to average volume of 3.11 million shares. In comparison with 52 week range of $6.50 - $10.20, it faced lowest price of $7.93 during the last trading session whereas its day highest price was $8.26. The company’s total market capitalization is $1.15 billion, along with 140.05 million shares outstanding. PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions.
Can PDLI Show a Strong Recovery? Find out in This Research Report
Galena Biopharma Inc (NASDAQ:GALE) showed 3,592,086 shares in volume during the last trading session, while the average trading volume remained 6.24 million shares. The stock kicked off its trading session at $4.11 and closed at $3.97. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Where GALE is Headed Exactly? Find out in This Trend Analysis Reports
MannKind Corporation (NASDAQ:MNKD) stock traded during its last trading session with the total traded volume of 3,570,200 shares versus its average volume of 4.44 million shares. The company opened its trade at the price of $5.00 and its closing price was $4.96. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
Is MNKD Buy After The Recent Price Movement? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)